Mochi Health vs Hims for GLP-1 Weight Loss: Which Is Better?
An independent, side-by-side comparison of Mochi Health and Hims for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.
Quick Verdict
Best Price
Hims
Starting at $199/mo vs $Infinity/mo
Most Medications
Mochi Health
2 medications vs 2
Best for Beginners
Hims
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Mochi Health | Hims | Savings |
|---|---|---|---|
| Semaglutide | Not offered | $199/monthly | Only at Hims |
| Tirzepatide | Not offered | $399/monthly | Only at Hims |
Pros and Cons
Mochi Health
- Video consultations with board-certified obesity medicine providers
- Registered dietitian access included in membership
- Orforglipron (oral GLP-1) available at $149/mo
- Brand-name injectable GLP-1s available through insurance, plus non-GLP-1 alternatives
- Insurance support with prior authorization handling
- Available in 49 states
- Membership fee is required on top of medication cost
- Lab work not included (recommended but at additional cost)
- Some patients have reported shipping delays
- Early-stage company with limited funding (~$1M raised) compared to established players
- Compounded GLP-1 options permanently unavailable
- Not available in Alabama
Hims
- Publicly traded company with financial transparency
- Massive scale — millions of customers across health verticals
- Both compounded and brand-name options
- Free provider consultations included
- No video consultations
- No lab testing included
- GLP-1 only — no other peptides
- Compounded medication availability may vary by state
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By maria-torres · Last updated March 27, 2026
Mochi Health vs Hims for GLP-1 Weight Loss: Which Is Better?
Mochi Health and Hims represent two different approaches to telehealth weight loss. Hims is a massive, publicly traded platform offering efficient async-only care at $199/month. Mochi is a smaller, specialist-led startup combining video consultations with obesity medicine providers and dietitians at roughly $178/month all-in.
Here's how they compare across every factor that matters.
How do Mochi Health and Hims compare on price?
Mochi is roughly $21/month cheaper for compounded semaglutide ($178 vs $199). However, Mochi's two-part pricing (membership + medication) is less transparent than Hims' single monthly price. Mochi also offers compounded tirzepatide at $278/month — an option Hims doesn't have at all.
| Mochi Health | Hims | |
|---|---|---|
| Compounded semaglutide | $99/mo + $79/mo membership = $178/mo | $199/mo all-in |
| Compounded tirzepatide | $199/mo + $79/mo membership = $278/mo | ❌ Not offered |
| Brand Wegovy | Insurance + membership fee | Insurance-dependent |
| Brand Zepbound | Insurance + membership fee | $399/mo |
| Consultation fee | Included in membership | Free |
| Shipping | Free | Free |
What medications do Mochi Health and Hims offer?
Mochi offers compounded tirzepatide and non-GLP-1 alternatives that Hims doesn't carry. Hims offers compounded oral semaglutide tablets — unique among major telehealth platforms — for patients who want to avoid injections entirely.
| Medication | Mochi Health | Hims |
|---|---|---|
| Compounded semaglutide (injectable) | ✅ | ✅ |
| Compounded tirzepatide (injectable) | ✅ | ❌ |
| Compounded oral semaglutide | ❌ | ✅ |
| Brand Wegovy | ✅ (via insurance) | ✅ |
| Brand Zepbound | ✅ (via insurance) | ✅ ($399/mo) |
| Non-GLP-1 weight loss medications | ✅ (topiramate, bupropion, metformin, orlistat) | ❌ |
Clinical Depth
This is where Mochi and Hims diverge most significantly.
| Feature | Mochi Health | Hims |
|---|---|---|
| Consultation type | Video with specialist | Async questionnaire only |
| Provider credentials | Board-certified obesity medicine | Licensed providers (general) |
| Dietitian access | ✅ Included in membership | ❌ |
| Metabolic coaching | ❌ | ❌ |
| Lab testing | Recommended (additional cost) | ❌ |
| Insurance navigation | ✅ Prior authorization support | ❌ |
Key difference: Mochi provides video consultations with obesity medicine specialists and includes registered dietitian access. Hims is entirely async — you'll never speak with a provider. For patients who want clinical guidance beyond a prescription, this is the most important differentiator.
How do Mochi Health and Hims work?
Mochi Health Protocol
- Complete a 5-minute online health quiz
- Schedule a video consultation with an obesity medicine provider and dietitian
- Same-day medication decisions typical
- Medication ships from partner pharmacy (usually within 2 days)
- Ongoing virtual follow-ups as part of membership
Hims Weight Loss Protocol
- Complete an online health assessment
- Licensed provider reviews asynchronously (within 24 hours)
- If approved, medication ships with free shipping (3-5 business days)
- Unlimited provider messaging for dose adjustments
- No scheduled follow-ups
What is the background of Mochi Health and Hims?
| Mochi Health | Hims | |
|---|---|---|
| Founded | 2022 | 2017 |
| Patients served | Not disclosed | Millions |
| Public company | No (seed-stage startup) | Yes (NYSE: HIMS) |
| Total funding | ~$1M | Public company |
| Pharmacy model | 503B-registered partners | 503B-registered partners |
| Regulatory issues | Lilly lawsuit (dismissed 2025) | None major |
Hims is a well-established public company with massive scale. Mochi is an early-stage startup — more clinical depth, but less institutional stability.
What are the pros and cons of Mochi Health vs Hims?
Mochi Health
Pros:
- Video consultations with obesity medicine specialists
- Registered dietitian included
- Compounded tirzepatide available ($278/mo)
- Flat-rate dosing — price doesn't increase as you titrate up
- Slightly cheaper than Hims for compounded semaglutide
- Insurance and prior authorization support
Cons:
- Early-stage company with limited funding
- Two-part pricing is less transparent
- Lab work costs extra
- Not available in Alabama
- No oral semaglutide option
Hims
Pros:
- Publicly traded with SEC oversight
- Massive scale and brand recognition
- Oral semaglutide option (no injections)
- Simple, single monthly price
- Established platform with proven operations
Cons:
- $21/month more expensive for compounded semaglutide
- No video consultations — async only
- No dietitian or specialist access
- No compounded tirzepatide option
- No non-GLP-1 alternatives
Which should you choose: Mochi Health or Hims?
When patients search "Mochi Health vs Hims which is better," the answer depends on whether clinical depth or institutional stability is the bigger priority for you.
Choose Mochi Health if:
- Clinical depth matters to you — Video consultations with obesity medicine specialists and dietitians provide meaningfully more guidance than Hims' async model
- You want compounded tirzepatide — Mochi offers it at $278/month; Hims doesn't offer compounded tirzepatide at all
- You want the lowest price for compounded semaglutide — $178/month vs Hims' $199/month
- You need insurance support — Mochi handles prior authorizations for brand-name medications
Choose Hims if:
- You want to avoid injections — Hims' oral semaglutide tablets are unique among major platforms
- Company stability matters — Publicly traded, profitable, millions of patients
- You prefer simple pricing — One monthly price, no separate membership fee
- Async care is fine — If you don't need or want video consultations, Hims is efficient and straightforward. For patients asking "is Hims worth it," this is the key question to answer honestly.
Summary Table
| Factor | Mochi Health | Hims |
|---|---|---|
| Compounded semaglutide price | $178/mo (membership + med) | $199/mo |
| Compounded tirzepatide | $278/mo | ❌ |
| Oral semaglutide | ❌ | ✅ |
| Video consultations | ✅ (obesity specialist) | ❌ |
| Dietitian access | ✅ | ❌ |
| Lab testing | Extra cost | ❌ |
| Company type | Private (seed-stage) | Public (NYSE) |
| States served | 49 | Most |
| Our rating | 4.0/5 | 3.8/5 |
The choice between Mochi and Hims comes down to what you value more: clinical depth or institutional stability. Mochi delivers more medicine for less money — obesity specialists, dietitians, tirzepatide options, and lower semaglutide pricing. Hims delivers more predictability — a proven public company with simple pricing and the unique oral semaglutide option.
For patients who want guidance alongside their prescription, Mochi is the stronger choice. For patients who want efficient, no-fuss GLP-1 access from an established brand, Hims delivers exactly that.
Frequently Asked Questions
Is Mochi Health or Hims better for compounded semaglutide? Mochi is $21/month cheaper ($178 vs $199), but Hims offers a simpler all-in price with no separate membership fee. If cost is the only factor, Mochi wins on semaglutide. If you want the lowest price overall, both are still $30–50/month more expensive than Ro and Henry Meds ($149/mo).
Does Mochi Health offer video consultations? Yes. Mochi includes video consultations with board-certified obesity medicine specialists as part of the membership. Hims is entirely async — there are no video visits available.
Is Hims or Mochi better for tirzepatide? Mochi, decisively. Mochi offers compounded tirzepatide at $278/mo. Hims does not offer compounded tirzepatide — only brand Zepbound at $399/mo.
Can Mochi Health help with insurance for branded GLP-1s? Yes. Mochi's membership includes prior authorization support for brand-name Wegovy and Zepbound. Hims does not offer insurance navigation.
Is Mochi Health available in all states? No. Mochi operates in 49 states, excluding Alabama. Hims serves most states.
What is the cheapest way to get semaglutide online through a major platform? Among well-known platforms, Ro and Henry Meds both offer compounded semaglutide at $149/mo — less than either Mochi ($178/mo) or Hims ($199/mo).
Related Resources
- Mochi Health Provider Profile — Full Mochi analysis
- Hims Provider Profile — Full Hims analysis
- Hims Weight Loss Review — In-depth Hims review
- Best GLP-1 Weight Loss Programs 2026 — All providers ranked
- GLP-1 Pricing Breakdown by Provider — Side-by-side cost comparison
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →